Hepatocellular carcinoma(HCC)
Conditions
Interventions
Postoperative adjuvant TACE:None
Only surgery:None
Postoperative Targeted and immunotherapy:None
TACE+Targeted and immunotherapy:None
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Patient age: 18-85 years; 2.Diagnosis confirmed as primary hepatocellular carcinoma (Hepatocellular Carcinoma, HCC), pathologically confirmed; 3.Underwent radical hepatectomy (R0 resection, no radiologically visible residual disease post-operation); 4.Good liver function (Child-Pugh A or stable B); 5.ECOG performance status: 0-1; 6.Complete clinical pathological data and follow-up information available;
Exclusion criteria
Exclusion criteria: 1.Evidence of extrahepatic metastasis before treatment; 2.A history of other malignant tumors in addition to hepatocellular carcinoma; 3.Severe comorbidities, including significant cardiopulmonary dysfunction and coagulopathy (International Normalized Ratio = 1.5); 4.Follow-up duration less than 3 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| OS;Cirrhosis;Total bilirubin;PLT;AST;Capsule invasion;Microvascular invasion;International Standardization Ratio;AFP;PT;ALT;ALB; | — |
Countries
China
Contacts
Public ContactXin Zheng
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed